The Clinical Trials for Effectiveness and Safety of the New Developed, Low powered Light Irradiation Equipment (Bye-Vi) for Patients with Common Cold, Single Center, Randomized Controlled, Parallel Design, Double Blinding, Superiority, Prospective Study

anobioimaging0 个研究点目标入组 20 人开始时间: 待定最近更新: 2023年5月2日

试验速览

暂无简介。

•1) Adult men and women aged 19 to 65
•2) Patients with cold symptoms 48 hours prior to participation in the test
•3) Those who have at least 1 point each of the 4 symptoms of sore throat, cough, sneeze, and runny nose, which are common local symptoms among the 8* cold symptoms
•4) Agreed not to take any cold-related medication while participating in clinical trials
•5) A person who fully understands the purpose and procedures of the study and wishes to participate in the clinical study with voluntary consent

•1) A person who has known light sensitivity or photoallergy
•2) A person whose body temperature is 37.5 degrees Celsius or higher
•3) Currently, people with allergic rhinitis, chronic obstructive pulmonary disease (COPD), and severe nasal syndrome
•4) A person with symptoms that may cause nasal congestion due to nasal polyps, past nasal/narcotic surgery, and score
•5) People with a history of alcoholism, drug abuse or prescription/nonconforming drug use (e.g. contraceptives, systemic steroids, nasal dosing, antibiotics, etc.)
•6) A person who has symptoms of infection other than respiratory tract

发起方

anobioimaging